Possible abnormal response to rocuronium in a patient taking multiple fitness supplements
We report a case of extremely rapid recovery of neuromuscular transmission (NMT) following rocuronium administration in a healthy female patient taking multiple 'muscle gain' supplements. The purpose of the report is to alert clinicians to a possible association between regular ingestion of these supplements and reduced duration of rocuronium effect, although we cannot exclude biological variability as the cause for the rapid offset. Patient consent for publication was obtained.
A 41-year-old woman was undergoing elective total laparoscopic hysterectomy to treat chronic pelvic pain and menorrhagia. She had no comorbidities and was a fit gym enthusiast. She smoked tobacco only occasionally and was taking no regular medications. She denied taking performance-enhancing drugs. However, she was taking a large number of micronutrient and protein supplements (see below). Her preoperative physical examination was unremarkable. Her weight was 64 kg, height 166 cm, body mass index 23.2 kg/m 2 and her percentage body fat was 13%.
In addition to standard monitoring, a quantitative NMT monitor (Datex-Ohmeda NMT Module) and processed electroencephalogram (BIS™) were used. Following oral premedication with midazolam 1.5 mg and routine intravenous induction with fentanyl 150 µg and propofol 160 mg, NMT baseline was set and rocuronium 40 mg (0.6 mg/kg, 2 x ED 95 1 ) was administered. Loss of NMT was observed in the expected time frame, and her trachea was intubated. Desflurane in oxygen/air was used as the maintenance anaesthetic.
Following patient positioning it was noticed that there already appeared to be significant recovery from neuromuscular blockade. This rapid recovery progressed to a train-of-four (TOF) ratio of 40% within 15 minutes of initial rocuronium administration. The typical recovery time after 0.3 mg/kg is quoted as 20-35 minutes 1 , and our patient had received twice this dose. A further 10 mg was given and the TOF ratio was moderately reduced for approximately five minutes. A further 20 mg was administered to produce adequate twitch suppression. Rapid recovery was again observed to a TOF ratio of over 80% by 30 minutes. A total dose of 1.1 mg/kg of rocuronium had been given by this point.
To facilitate completion of the laparoscopic procedure, further muscle relaxant was requested by the surgical team. Given the rapid recovery following multiple doses of rocuronium, atracurium 20 mg was administered. This produced relatively rapid and long-lasting relaxation adequate Correspondence for the remainder of the procedure. Subsequent reversal of neuromuscular block was routine with neostigmine 2.5 mg/ glycopyrrolate 500 µg and the patient made an uneventful recovery. On the first postoperative day the patient was advised of the unexpected response to rocuronium and a brief letter was provided for her to present to her anaesthetist should she require anaesthetic care in the future.
Variability in response to neuromuscular blocking drugs is considerable even in a relatively homogeneous population 1 . At a fundamental level, duration of block will be determined by the sensitivity of the patient's neuromuscular junction to the agent in question (pharmacodynamic factors) and the prevailing drug concentrations in both the plasma and at the effect site (pharmacokinetic factors). There are many potential contributors to this variability including temperature, electrolyte abnormalities, neuromuscular disease, hepatic or renal disease, drug interactions and gender 1,2 . The per kilogram dose required for any given effect in females may be only 70% of that required in males 3, 4 , making our patient's dose requirement even more remarkable.
While the rapid recovery we observed in this patient may represent normal biological variability, we cannot ignore the possibility that there may be an association between the observed response and the only other unusual feature of this patient, which was the large number of muscle gain supplements and her exercise regimen. An association may have some biological plausibility. Laboratory research on the effect of resistance training on the neuromuscular junction in rats has shown increases in both length and area of the motor endplate by approximately 15%, causing dispersion of acetylcholine receptors within this enlarged endplate region 5 . However, to our knowledge, there have been no studies on the effect of resistance training or fitness supplement ingestion on neuromuscular transmission in humans, or previous reports of abnormal responses to rocuronium in this group of patients. In our patient, the repeated rapid offset of rocuronium suggests a pharmacokinetic effect. The typical duration of block with a small dose of atracurium indicates that this rapid offset was not related to all muscle relaxants.
The case described could possibly be attributed to reduced rocuronium activity in the ampoule, i.e. the drug was faulty. This seems unlikely as onset of blockade was within the expected time frame, the effect was observed over two undiluted ampoules which would then imply a faulty batch, and our observations were not repeated in preceding or subsequent relaxant cases.
Use of quantitative NMT monitoring in this case allowed immediate detection of unexpected offset of blockade and triggered appropriate intervention to facilitate safe surgery and recovery. Unanticipated and undetected block recovery during surgery may interfere with controlled ventilation and may have adverse consequences as unanticipated intraoperative movement could result in patient morbidity. It is the authors' opinion that regular automated NMT monitoring and real-time display of results offers significant advantages over intermittent qualitative monitoring achieved with peripheral 'eye and feel' nerve stimulators. We advocate the use of quantitative NMT monitoring in all cases, and found the information provided invaluable in this case. The Australian and New Zealand College of Anaesthetists guidelines on monitoring during anaesthesia (PS18) have recently been revised, and the current recommendation is that 'quantifiable' neuromuscular function monitoring must be available whenever a non-depolarising muscle relaxant is used 6 .
While we can draw no firm conclusions from this single case, we recommend caution and close NMT monitoring if neuromuscular blockade is used in patients taking fitness supplements and undertaking regular resistance training. We would be very interested to hear if other clinicians have had similar experiences with similar patients taking large doses of fitness supplements to determine whether this is a real association.
Supplements regimen:
Glass of apple cider vinegar with lemon juice and water plus 2 g of vitamin C soluble tablet, mane.
Nutrex Research™ Lipo-6 CLA (Concentrated Linoleic Acid) 1000 mg/tablet, 2 tablets TDS. Narlabs™ Micronized Branched Chain Amino Acids; 4,800 mg/tablet: 2 tablets TDS-QID (dependent on training regimen) USN Core Series™ Glutamine; 2.5 g, OD-BD (dependent on training regimen) Narlabs™ Hydrogenised whey protein shake; 30 g (preworkout)
Training regimen: On season-3 sessions per day. Body fat 7% by mass.
Off season-2 sessions per day. Body fat 13% by mass (current season).
